HOSPITAL UNIVERSITARIO RUBER
Saila
Washington University in St. Louis
San Luis, Estados UnidosWashington University in St. Louis-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2021
2018
-
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
The Lancet Oncology, Vol. 19, Núm. 6, pp. 812-824